Hims & Hers Health, INC Schedule 13G passive stakes

Vanguard Capital Management has reported beneficial ownership of over 11.18 million shares, representing 5.01% of Hims & Hers Health Inc.'s common stock.

Susquehanna Investment Group and affiliated entities have reported beneficial ownership of 14,502,395 shares, representing 6.5% of Hims & Hers Health, Inc.'s Class A Common Stock as of March 31, 2026.

Capital World Investors has filed an amendment to its Schedule 13G, reporting beneficial ownership of 2 shares of Hims & Hers Health, Inc. common stock as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Hims & Hers Health Inc. following an internal corporate realignment.

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, reporting a 1.7% beneficial ownership in Hims & Hers Health, Inc.'s Class A common stock.

Capital World Investors has reported a 6.5% beneficial ownership stake in Hims & Hers Health, Inc., holding over 14.3 million shares.

JPMorgan Chase & Co. has reported a beneficial ownership of 8.1% in Hims & Hers Health, Inc.'s Class A common stock as of September 30, 2025.

Capital World Investors has disclosed a significant 8.6% beneficial ownership stake in Hims & Hers Health, Inc. common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 10.8% of Hims & Hers Health Inc.'s Class A Stock as of March 31, 2025.